Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01232556 |
|---|---|
| Brief Title: | A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy |
| First Submitted : | October 27, 2010 |
| First Submitted that Met QC Criteria : | October 29, 2010 |
| First Posted : | November 2, 2010 (Estimate) |
| Results First Submitted : | July 17, 2017 |
| Results First Submitted that Met QC Criteria : | July 24, 2018 |
| Results First Posted : | August 21, 2018 |
| Certification/Extension First Submitted : | May 29, 2014 |
| Certification/Extension First Submitted that Met QC Criteria : | May 29, 2014 |
| Certification/Extension First Posted : | June 2, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 19, 2018 |
| Last Update Posted : | January 8, 2019 |